Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001114220-18-000043
Filing Date
2018-04-30
Accepted
2018-04-30 17:23:51
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A kerx-12312017x10ka.htm 10-K/A 796653
2 EXHIBIT 31.1.2 kerx-12312017x10kaex3112.htm EX-31.1.2 18037
3 EXHIBIT 31.2.2 kerx-12312017x10kaex3122.htm EX-31.2.2 7019
  Complete submission text file 0001114220-18-000043.txt   822686
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30929 | Film No.: 18791486
SIC: 2834 Pharmaceutical Preparations